Aldeyra Therapeutics Inc (NASDAQ: ALDX) on Monday, soared 5.44% from the previous trading day, before settling in for the closing price of $4.96. Within the past 52 weeks, ALDX’s price has moved between $1.14 and $7.20.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 15.99%. The company achieved an average annual earnings per share of 34.84%. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Aldeyra Therapeutics Inc is 3.25%, while institutional ownership is 65.77%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.27 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Aldeyra Therapeutics Inc (ALDX) is currently performing well based on its current performance indicators. A quick ratio of 2.68 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Compared to the last year’s volume of 1.05 million, its volume of 0.64 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 41.75%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 54.01%, which indicates a significant decrease from 85.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.17, while its 200-day Moving Average is $4.61. Nevertheless, the first resistance level for the watch stands at $5.37 in the near term. At $5.51, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.72. If the price goes on to break the first support level at $5.02, it is likely to go to the next support level at $4.81. Should the price break the second support level, the third support level stands at $4.67.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
Market capitalization of the company is 314.65 million based on 60,163K outstanding shares. Right now, sales total 0 K and income totals -55,850 K. The company made 0 K in profit during its latest quarter, and -7,690 K in sales during its previous quarter.
